作者
Ji Son,Yingao Zhang,Heather Lin,Oriol Mirallas,Pablo Álvarez Ballesteros,Mirella Nardo,Natalie Clark,R. Tyler Hillman,Erick Campbell,Vijaykumar Holla,Amber M. Johnson,Amadeo B. Biter,Ying Yuan,Lauren P. Cobb,David M. Gershenson,Amir A. Jazaeri,Karen H. Lu,Pamela T. Soliman,Shannon N. Westin,Elizabeth D. Euscher,Barrett C. Lawson,Richard K. Yang,Funda Meric‐Bernstam,David S. Hong
摘要
We aimed to describe RAS mutations in gynecologic cancers as they relate to clinicopathologic and genomic features, survival, and therapeutic implications.